CLINICAL ROLE -
What Impact Does DIR Fees Have on Specialty Pharmacies?
Rinku Patel, PharmD, RPh, CEO and founder of KloudScript, discusses the impact of direct and indirect remuneration (DIR) fees.
Read More
Revamped Housing Program Targets Regions with High Rates of HIV
Housing Opportunities for Persons With AIDS program awarded $320.4 million to qualifying states and local jurisdictions.
Trending News Today: Colorectal Cancer Rate Increases in White Adults
Top news of the day from across the healthcare landscape.
Trending News Today: New Hampshire Sues OxyContin Manufacturer for Alleged Role in Opioid Epidemic
Top news of the day from across the health care landscape.
Barbershops Serve as Platform to Encourage Colorectal Cancer Screening Among Black Men
Study findings highlight the importance of community-based health interventions that target cancer prevention.
FDA Grants Priority Review for Rare Blood Disease Drug
Approval sought for vemurafenib (Zelboraf) to treat Erdheim-Chester disease with BRAF V600 mutation.
Resistance Training May Slow Multiple Sclerosis Progression
Physical training further minimizes brain shrinkage in MS patients already receiving medication.
Domestic Violence More Likely to Start After HIV Diagnosis for Pregnant Women
Partner violence negatively impacts the ability of women with HIV to adhere to antiretrovirals.
Trending News Today: Electronic Chip Heals Mice Wounds in New Study
FDA Advisory Panel Votes in Favor of Investigational Hepatitis B Vaccine
Heplisav-B aims to boost a patient’s own immune response to fight off HBV.
Trending News Today: Jury Convicts Notorious Price-Gouger Martin Shkreli
HIV-Specific Broadly Neutralizing Antibody Minimally Impacts Time to Viral Rebound Following ART Interruption
The study is the first to evaluate VRC01 antibody in patients who started antiretroviral therapy during acute HIV infection.
EU Approves Pan-Genotypic Drug for Chronic Hepatitis C Virus
Maviret is an 8-week treatment that combines 2 distinct antiviral agents.
FDA Advisory Committee Backs Pending Approval of Xeljanz to Treat Psoriatic Arthritis
If approved, Xeljanz will be the first Janus kinase inhibitor for psoriatic arthritis.
Reported Cases of HIV-Infection Increases 140% in Philippines
Pilot project to bring pre-exposure prophylaxis to the Philippines for the first time.
Trending News Today: Telehealth Program Aims to Improve Veteran Care
FDA Grants Durvalumab Breakthrough Therapy Designation for Locally-Advanced Lung Cancer
Durvalumab is indicated to treat patients with locally-advanced, unresectable non-small cell lung cancer.
Exploiting Cancer's Achilles Heel to Improve Treatment Options
Targeting cell mutations could disrupt tumor cell growth without harming non-cancerous cells.
FDA Advisory Committee Does Not Recommend Sirukumab
Although the FDA is not bound by the recommendation of the committee, their advice is taken into consideration.
Eight-Week Hepatitis C Regimen Gets FDA Approval
Mavyret approved for chronic hepatitis C virus genotypes 1-6 without cirrhosis or with mild cirrhosis.
FDA Approves Mavyret to Treat All Major Hepatitis C Genotypes
Combination therapy cuts standard HCV treatment regimen from 12 weeks to 8 weeks.
Alectinib Granted Priority Review for First-Line Treatment of ALK-Positive Lung Cancer
An approval decision for Alecensa is expected by November 30, 2017.
FDA Advisory Committee Votes Against Recommendation of Sirukumab
Sirukumab is designed to treat adults with moderately-to-severely active rheumatoid arthritis.
Blood Glucose Control Lessens Risk of Heart Disease in Type 1 Diabetes
Glycemic control may reduce cardiovascular disease-related mortality among older patients with type 1 diabetes.
Hope for HIV: Vaccine Regimen Elicits Immune Responses Against HIV
Research advances hunt for a safe and effective preventative HIV vaccine.
Vyxeos Approved as First Treatment for High Risk Acute Myeloid Leukemia
Vyxeos is a combination chemotherapy that treats a pair of high-risk subsets of acute myeloid leukemia.
FDA Approves First Treatment for High-Risk Acute Myeloid Leukemia
Vyxeos is indicated to treat newly diagnosed therapy-related AML or AML with myelodysplasia-related changes.
Novel Stem Cell Method May Offer an Alternative to Treat Cancer Metastasis
The approach only targets metastatic tissue, reducing negative adverse events associated with chemotherapy.
Trending News Today: Molina Healthcare to Exit ACA Insurance Exchanges in 2 States
Hepatitis E Virus Could Become a Concern Among Developed Countries
HEV is reemerging as a zoonotic virus, with individuals becoming infected via pigs and pork products.